[Indications study--Fluad 2003/2004].
Kondler-Budde
Roswitha
R
Chiron Behring GmbH & Co, Marketing und Verkauf Deutschland, Marburg.
D000368:Aged; D000369:Aged, 80 and over; D000914:Antibodies, Viral / Q000276:immunology; D017277:Drug Approval / Q000331:legislation & jurisprudence; D005858:Germany; D006801:Humans; D007252:Influenza Vaccines; D007251:Influenza, Human / Q000276:immunology / Q000401:mortality / Q000451:nursing* / Q000517:prevention & control; D011358:Product Surveillance, Postmarketing; D012621:Seasons; D015996:Survival Rate; D016896:Treatment Outcome; D014612:Vaccines / Q000008:administration & dosage* / Q000276:immunology
D000914:Antibodies, Viral; D007252:Influenza Vaccines; D014612:Vaccines; C478243:fluad vaccine